Vitrolife AB (publ)
VITR
Rank in Stocks
#6578
Vitrolife AB (publ) is a medical technology company specializing in the... Vitrolife AB (publ) is a medical technology company specializing in the development, production, and global sale of products for assisted reproduction. Their comprehensive offering includes a variety of essential tools for fertility treatments, such as oocyte retrieval needles, sperm processing solutions, specialized in vitro fertilization media and oils, and micromanipulation pipettes. The company also provides general labware, incubators, cryopreservation products, and systems for preimplantation genetic testing. Furthermore, Vitrolife delivers advanced equipment, including the EmbryoScope and Primo Vision time-lapse systems, along with dedicated dishes and evaluation software for these platforms. Their technology portfolio extends to Octax laser and imaging systems, as well as environmental monitoring solutions like log and guard systems and wireless sensors. With its headquarters located in Gothenburg, Sweden, Vitrolife maintains a significant international presence, operating across Europe, the Middle East, and Africa; Asia; Japan and the Pacific; and both North and South America. Founded in 1994, the company was initially known as Scandinavian IVF Science before officially changing its name to Vitrolife AB (publ) in 1998.
Share Price
$11.88
Last synced: 2026-11-13
Market Cap
$1.59B
Change (1 day)
0.51%
Change (1 year)
-21.27%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Vitrolife AB (publ) (VITR)
Category
Healthcare
EPS for Vitrolife AB (publ) (VITR)
EPS as of September 2026 TTM: $-3.63
According to Vitrolife AB (publ)'s latest financial reports, its current EPS (TTM) is $-3.63. At the end of 2025 the company had an EPS of $-4.01, a decrease compared to its 2024 EPS of $0.34.
EPS history for Vitrolife AB (publ) from 2002 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-3.63 | -9.41% |
| 2025 | $-4.01 | -1,267.35% |
| 2024 | $0.34 | -112.19% |
| 2023 | $-2.82 | -1,110.07% |
| 2022 | $0.28 | -14.96% |
| 2021 | $0.33 | 2.72% |
| 2020 | $0.32 | -15.50% |
| 2019 | $0.38 | 18.53% |
| 2018 | $0.32 | 7.34% |
| 2017 | $0.30 | 54.31% |
| 2016 | $0.19 | -3.31% |
| 2015 | $0.20 | 42.59% |
| 2014 | $0.14 | 57.85% |
| 2013 | $0.09 | -83.11% |
| 2012 | $0.52 | 1,064.67% |
| 2011 | $0.05 | 0.67% |
| 2010 | $0.04 | -8.78% |
| 2009 | $0.05 | 27.94% |
| 2008 | $0.04 | -31.48% |
| 2007 | $0.06 | 155.25% |
| 2006 | $0.02 | 8.96% |
| 2005 | $0.02 | -4.74% |
| 2004 | $0.02 | -69.02% |
| 2003 | $0.07 | -53.29% |
| 2002 | $0.15 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -174.32% |
US
|
|
| $4.09 | -212.59% |
IE
|
|
| $9.45 | -360.14% |
US
|
|
| $2.37 | -165.24% |
US
|
|
| $1.77 | -148.72% |
US
|
Questions about Vitrolife AB (publ)'s earnings per share (EPS)
What is Vitrolife AB (publ)'s earnings per share (EPS)?
Vitrolife AB (publ)'s earnings per share (EPS) over the last twelve months is $-3.63, as of Sep 2026.
What was Vitrolife AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Vitrolife AB (publ)'s earnings per share (EPS) was $-4.01, compared with $0.34 in 2024.
How has Vitrolife AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Vitrolife AB (publ)'s earnings per share (EPS) was highest in 2024 ($0.34) and lowest in 2025 ($-4.01).
How does Vitrolife AB (publ)'s earnings per share (EPS) compare with similar companies?
Vitrolife AB (publ)'s earnings per share (EPS) ($-3.63) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.